Isofol Medical AB (publ) announced that Chief Executive Officer Dr. Ulf Jungnelius M.D. and Isofol's Board of Directors have agreed that Ulf will step down as CEO of Isofol on June 1, 2023. Isofol's Board of Directors will take a decision regarding a new CEO once the company's future has been determined. Dr. Ulf Jungnelius M.D. and Isofol have agreed that Ulf will leave his position as CEO of Isofol Medical on June 1, 2023.

Until then he will be fully focused in leading Isofol as it completes the closure of the AGENT and to assess possible future paths forward for the Company.